Association Of Carotenoid Intake With Pulmonary Function by Jun, Lauren Yourim & NC DOCKS at Appalachian State University
 
 
 
 
 
 
 
 
ASSOCIATION OF CAROTENOID INTAKE WITH PULMONARY FUNCTION 
 
 
 
 
 
 
 
A Thesis  
by 
LAUREN YOURIM JUN 
 
 
 
 
 
 
Submitted to the School of Graduate Studies 
 at Appalachian State University 
in partial fulfillment of the requirements for the degree of 
MASTER OF SCIENCE 
 
 
 
 
 
 
 
 
 
May 2020 
Department of Nutrition and Health Care Management 
 
 
 
 
  
 
 
 
ASSOCIATION OF CAROTENOID INTAKE WITH PULMONARY FUNCTION 
 
 
 
 
 
A Thesis  
by 
LAUREN YOURIM JUN 
May 2020 
 
 
 
 
 
APPROVED BY:  
  
 
        
Martin Root, PhD 
Chairperson, Thesis Committee 
 
 
        
Jamie Griffin, PhD 
Member, Thesis Committee 
 
 
        
Kyle Thompson, DCN, RDN 
Member, Thesis Committee 
 
 
        
Margaret Barth, PhD, MPH 
Chairperson, Department of Nutrition and Health Care Management 
 
 
        
Mike McKenzie, Ph.D. 
Dean, Cratis D. Williams School of Graduate Studies 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by Lauren Jun 2020 
All Rights Reserved
iv 
Abstract 
 
ASSOCIATION OF CAROTENOID INTAKE WITH PULMONARY FUNCTION 
 
Lauren Jun 
B.S., Appalachian State University 
 
Chairperson:  Martin Root, Ph.D. 
 
Lung function gradually declines as adults age, which can make breathing more 
difficult. Previous studies have reported enhanced lung function among older adults with 
high intake of carotenoid-rich foods. The aim of this study is to investigate the association 
between carotenoid-rich diet and lung function. 
 Data were taken from the Atherosclerosis Risk in Communities (ARIC) study, which 
included approximately 15,000 individuals aged 45-64 years at baseline from each of four 
counties in the United States. Food frequency questionnaire (FFQ) data were used to assess 
dietary intake of carotenoid-rich foods. Total carotenoids intake was calculated by adding 
five specific carotenoids – α-carotene, β-carotene, β-cryptoxanthin, lycopene, and 
lutein/zeaxanthin. Pulmonary function was evaluated as the ratio of forced expiratory volume 
in one second [FEV1] and forced vital capacity [FVC]. Linear regression analysis was used to 
assess the association between intake of carotenoids and pulmonary function. 
The association between the total carotenoid intake with pulmonary function was 
marginally positively significant; however, α-carotene, β-carotene, and β-cryptoxanthin 
intakes were individually significantly associated with a higher FEV1/FVC ratio in study 
participants. 
Dietary sources of pro-vitamin A carotenoids include yellow/orange fruits and 
vegetables such as oranges and sweet potatoes. Higher intake of these foods may improve 
pulmonary function.  
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Chapter One 
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in 
the world and is projected to be the third leading cause of death by 2020 (1). According to 
the Global Initiative for Chronic Obstructive Lung Disease, more than three million people 
died of COPD in 2012, which is six percent of all deaths globally (1). Based on large scale 
epidemiological studies, the number of COPD cases was estimated to be 384 million in 2010, 
with a global prevalence of 11.7% (1).  
COPD is an inflammatory disease leading to obstructive lung airways and airflow 
limitations (2) that interferes with normal breathing (3). These problems, caused by a 
narrowing airway lumen diameters (e.g., obstructive bronchiolitis) and parenchymal 
destruction (emphysema) develop as a result of varying perturbations in both airway and 
interstitial lung tissue (4). The chronic inflammation experienced in COPD causes structural 
changes, narrowing of the small airways and destruction of the lung parenchyma that leads to 
the loss of alveolar attachments to the small airways and decreases lung elastic recoil, 
diminishing the ability of the airways to remain open during expiration (1).  
A COPD diagnosis is considered in any patient with the following symptoms of a 
chronic cough, sputum production, dyspnea, and a history of exposure to risk factors for the 
disease such as chemical or environmental exposure and family history. Diagnosis is 
confirmed by a spirometry test, which measures how fast air can move in and out of the lungs 
and how deeply a person can breathe (5). More specifically, the ratio of the forced expiratory 
volume in 1 second (FEV1) to the total vital capacity (FVC) is used to define the severity of 
the disease (6). COPD is partially classified by a FEV1/FVC ratio of less than 0.70 and an 
FEV1 less than 80% of that predicted by age, sex, ethnicity, and standing height (7). 
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COPD is not common before the age of 40, but symptoms of hypersecretion occur 
with increasing frequency after that age (4). In fact, more than 10% of individuals over 50 
years of age develop COPD (4). At an older age, increased wall thickening, intraluminal 
mucus accumulation, smooth muscle hypertrophy, and small airway lining fluid changes may 
occur (4) leading to reduced lung function (4). Due to variable signs and symptoms of COPD 
and other similar conditions that are attributed to older age, irregularities in pulmonary 
function are often misdiagnosed or diagnosed too late (4).  
COPD development is due mainly to biological factors such as inflammation and 
oxidative stress caused by free radicals, and inadequate intake of antioxidant-rich foods (8). 
Augmented pollution from rapid industrialization and increases in the smoking rates 
worldwide also increase risk for developing COPD (9). According to Scanlon et al. (10), risk 
factors to the development of COPD include tobacco smoking, poor initial lung function, 
advanced age, male sex, childhood respiratory illness, occupational respiratory exposures, air 
pollution, low educational attainment or socioeconomic status, and other familial factors. 
Individuals with COPD and smokers without airflow obstruction show an increased number 
of inflammatory cells infiltrating the adventitia of pulmonary muscular arteries.  
Another epidemiological study investigated the prevalence and incidence of COPD 
by age, sex, and smoking status with 25 years of follow-up. COPD was diagnosed based on 
obstructive pre-bronchodilator spirometry (FEV1/FVC) according to the Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) guidelines (FEV1/FVC<70%). The study found 
an increased overall incidence rate of COPD with age, higher in men than in women, and 
with smokers compared to non-smokers (11).   
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In recent studies, cigarette smoke products have been shown to be an initiating factor 
for the pulmonary vascular derangement in COPD (12). A study by Lundbäck et al. (13) in 
2003 stated that approximately 50% of smokers may develop COPD. Additionally, it has 
been noted that nearly 90% of all COPD patients are smokers (4). Moreover, tobacco use is 
currently the single most significant and most preventable cause of illness and death in the 
world, killing approximately 6 million people a year (14). Cigarette smoke is a major source 
of oxidants, containing an estimated 1018 spins (electron spin resonance) per gram of tar 
(particulate matter which is generated by burning tobacco) (4). These radicals are sufficiently 
stable to be detected by electron spin resonance and may reduce oxygen to O2 (4). Secondly, 
smoking was found to be the cause of airway and parenchymal inflammation in most COPD 
patients (4). Airway assessment was performed by sputum analysis, bronchoscopy, biopsy, 
and lung lavage in COPD patients and suggested that inflammation was a contributing factor 
to the development of COPD (4). 
Oxidative stress, an imbalance between an excess of oxidants and insufficient 
antioxidant resources, appears to trigger a number of inflammatory, obstructive, and fibrotic 
lung disorders and contributes to the development of COPD (15). This imbalance is known to 
play an important role in the pathogenesis of the disease through direct injurious effects, and 
by involvement in the molecular mechanisms that control lung inflammation (16). The 
formation from oxygen to superoxide anion (O2-), an oxygen radical, is generated primarily 
by mitochondrial metabolism reactions, arachidonic acid metabolism, and NADPH oxidase-
dependent processes in phagocytic cells (4). The reaction of O2- and hydrogen peroxide 
(H2O2) produces the hydroxyl radical (-OH), and when catalyzed by neutrophil 
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myeloperoxidase (MPO), H2O2 and a chloride form hypochlorous acid (HOCl) (4). Both -OH 
and HOCl are extremely potent oxidants in human bodies(4).  
A major consequence of oxidative stress is lipid peroxidation (17). Lipid peroxidation 
is induced by oxygen in the presence of initiators such as heat, other free radicals, light, 
photosensitizing pigments, and metal ions (18) which can permanently damage cell 
membranes, eventually leading to cell death (17). Lipid oxidation occurs via three reaction 
pathways: non-enzymatic chain autoxidation mediated by free radicals, non-enzymatic and 
nonradical photooxidation, and enzymatic oxidation (18). One end product of lipid 
peroxidation, 4-hydroxy-2-nonenal (HNE) for example, may lead to subsequent pathological 
consequences such as potentiating oxidative stress through depletion of intracellular 
glutathione and inducing peroxide production (17). HNE has shown to play a role in airway 
remodeling through activation of the epidermal growth factor receptor and induction of 
fibronectin production (17). Lastly, past studies have suggested that HNE may induce cell 
death of alveolar macrophages in mice (17).  
Reactive oxygen species (ROS), such as superoxide anion, hydrogen peroxide, and 
hydroxyl radicals (17), are generated by inflammatory cells in the lung in response to 
different stimuli, including tobacco smoke (15). Past studies have found that large numbers 
of neutrophils and macrophages in the lungs of COPD patients generate ROS in excess such 
that these patients have higher levels of superoxide anion and hydrogen peroxide release 
(17). Ciencewicki et al (17). have observed impairment in gene expression of protective 
mechanisms against oxidants in lung samples of COPD patients along with upregulation of 
chemokines involved in the inflammatory processes. The authors also observed locally 
generated 4-HNE modifying protein levels in the airway and alveolar epithelial cells, and 
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endothelial cells in individuals with airway obstruction, even interacting with glutathione, 
thereby reducing cells’ antioxidant ability (17).   
The human body has several mechanisms to counteract oxidative stress by producing 
antioxidants, or utilizing externally supplied antioxidants through food and supplements (19). 
Antioxidants can be categorized as either enzymatic and non-enzymatic antioxidants (20). 
Plant-based antioxidants, vitamin C, vitamin E, carotenoids, and glutathione, are examples of 
non-enzymatic antioxidants. Antioxidants have been receiving interest in the research field 
over the past 30 years. According to Halliwell and Gutteridge (18), an antioxidant is defined 
as “a substance that, when present at low concentrations compared to those of an oxidizable 
substrate, significantly delays or prevents oxidation of the substrate.” An antioxidant-rich 
diet came to public attention recently due to its role in human health. Collectively, the 
Mediterranean diet became the supreme diet to the public. 
The Mediterranean diet has been known to have protective effects for respiratory 
diseases in epidemiological studies. The Mediterranean diet pattern consists of high intake of 
minimally processed whole plant foods such as fruits, vegetables, bread, cereals, beans, nuts, 
seeds, red wine, and olive oil, low to moderate consumption of dairy foods, fish, poultry, and 
red meat (21). Several studies in the past found an inverse association between adherence to 
the Mediterranean diet and atopy, wheezing, and asthma symptoms among children and 
adults (22). The typical western diet pattern, on the other hand, consists of high 
consumptions of refined grains, cured and red meats, sweets and sweetened beverages, fried 
foods, and high-fat dairy products. This pattern of intake has been associated with increased 
risk of respiratory-related diseases such as asthma in children (23) and adults (24). 
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Additionally, a diet consisting of high-fat foods has been shown to worsen airway 
inflammation and increase the risk of COPD (25).  
Fruits and vegetable intake has been known for its prominent effect in respiratory 
conditions due to their nutrient profile containing antioxidants, vitamins, minerals, fiber, and 
phytochemicals (26). In a past study, increased fruit intake over two years was associated 
with increased FEV1, while another study found that a significant decrease in fruit intake 
over seven years was associated with decreased FEV1 (27). Wood et al.(28) conducted an 
intervention in adults with asthma and found that high consumption of fruits and vegetables 
for three months was associated with a reduced risk for asthma exacerbation. Two 
randomized controlled trials conducted in COPD patients observed no effect of a high fruit 
and vegetable intake on FEV1 over a 12-week period; however, a 3-year study showed an 
improvement in lung function in high fruit and vegetable group compared to the control 
group (29). This result suggests that a longer-term intervention is needed to provide a 
therapeutic effect.  
A study conducted by Meteran et al. (30) examined the association between self-
reported intake of fruits and vegetables and risk of COPD. The study recruited 12,449 twins, 
between 40 to 80 years of age, from 2008 to 2011 (30). The questionnaire included lifestyle 
factors, including smoking status, fruits and vegetable intake, degree of physical activity, and 
respiratory symptoms. A pre-bronchodilator lung function test was performed using a 
spirometry test and COPD was diagnosed based on the reference values from the Global 
Lung Initiative 2012. A logistic regression, including sex, age, and BMI as covariates, 
showed that smoking was an independent predictor of COPD (30). Furthermore, the study 
found that increase in number of servings of raw fruits and vegetables was associated with a 
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significant decrease in risk of COPD (30). This result suggests that raw fruits and vegetables 
are superior to cooked or processed fruits and vegetables due to higher antioxidant content.  
As mentioned above, antioxidants counteract oxidation by protecting target lipids and 
other target molecules from oxidation (18). It can prevent lipid peroxidation by hindering 
ROS formation or scavenging species responsible for oxidation initiation (17). Secondly, 
antioxidants can intercept radical oxidation propagators or indirectly participate in stopping 
radical chain propagation, and thus prevent peroxidation of lipids (17). To understand how 
non-enzymatic antioxidants protects lipids from oxidation, the mechanisms of antioxidant 
activity must be explained.  
Vitamin E, α-tocopherol, is an efficient lipid-soluble antioxidant that functions as a 
‘chain breaker’ during lipid peroxidation in cell membranes and several lipid particles such 
as low-density lipoprotein (LDL) (20). It intercepts lipid peroxyl radicals (-LOO) and 
terminates the lipid peroxidation chain reaction, hence the name ‘chain breaker.’ The 
subsequent tocopherol radical is now relatively stable and insufficiently reactive to initiate 
lipid peroxidation itself.  
Vitamin C, ascorbic acid, is a water-soluble free radical scavenger which regenerates 
vitamin E in cell membranes in combination with glutathione (GSH) (20). Vitamin C 
changes to the ascorbate radical by donating an electron to the lipid radical in order to 
stabilize it and therefore terminate the lipid peroxidation chain reaction (31).  
Carotenoids, some of the most common lipid soluble phytonutrients, are known to 
scavenge the peroxyl radicals more efficiently as compared to any other ROS (20). 
Scavenging of these radicals can disrupt the reaction sequence and prevent the damage to 
cellular lipids (20). Carotenoids are also known to protect cellular membranes and 
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lipoproteins against the ROS due to their peroxyl radical scavenging activity, where 
carotenoids deactivate the peroxyl radicals by reacting with them to form resonance 
stabilized carbon-centered radical adducts (20).  
A study in 2000 analyzed the effects of vitamin C, E, β-carotene, and selenium intake 
and used both dietary assessment and serum biomarkers of antioxidant status using data from 
the Third National Health and Nutrition Examination Survey (32). The survey was conducted 
from 1988 through 1994 on a nationwide sample of approximately 33,994 participants aged 
two months and older (32). Along with the intake of dietary antioxidants, the authors 
included the number of cigarettes currently smoked per day. Multiple linear regression 
analysis was used to examine the separate and joint effects of the antioxidants on FEV (32). 
As results, the authors found that each of the dietary and serum antioxidant nutrients was 
significantly associated with FEV1. Although serum β-carotene was less positively associated 
with FEV1 in smokers than non-smokers, serum selenium had a strong positive association 
with FEV1 in smokers (32). 
A study conducted in 1998 investigated the relationship between the intake of vitamin 
C, E, and β-carotene and the presence of respiratory symptoms and lung function as part of 
the MORGEN study (the Monitoring Project on Risk Factors and Health in the Netherlands) 
(33). The study sample was randomly selected from a cross-sectional study in the Dutch 
population on 6,555 adults during 1994 and 1995 (33). After collecting data on dietary intake 
and respiratory symptoms, logistic regression analysis was used for FEV1 and FVC rate (33). 
According to the results, the intake of vitamin C was not associated with most respiratory 
symptoms, but subjects with a high intake of vitamin C had a 53mL (95% CI 23 to 83) higher 
FEV1 and 79mL (95% 42 to 116) higher FVC than those with a low vitamin C intake (33). 
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Similarly, vitamin E intake showed no association with most symptoms and pulmonary 
function. The intake of β-carotene also showed no association with most symptoms; 
however, subjects with a high intake of β-carotene had a 60 mL (95% CI 31 to 89) higher 
FEV1 and 75 mL (95% CI 50 to 110) higher FVC than those with a low intake of β-carotene 
(33). These results showed that a high intake of vitamin C or β-carotene may be protective 
for FEV1 and FVC compared with a low intake (33).  
Similarly, Kentson et al. (15) studied the relationship between oxidative stress, iron 
homeostasis, and plasma levels of carotenoids in patients. This study involved 66 Caucasians 
with advanced COPD and 47 healthy control subjects. Overall health, lifestyle, and dietary 
habits were asked in questionnaires, and lung function tests and blood sampling were 
performed in both groups (15). Results showed that COPD subjects had significantly lower 
plasma levels of β-cryptoxanthin, α- and β-carotenes, and ate significantly less fruits and 
vegetables in their diet compared to the control group (p<0.05) (15). The study also found 
that a diet with high consumption of fruits, vegetables, whole grains, polyunsaturated fatty 
acids, nuts, and long-chain omega-3 fats and low consumption of red and processed meat, 
refined grains, and sugar-sweetened drinks was associated with a lower risk of COPD (15). 
Recent data describe the beneficial effects of dietary fiber intake on pulmonary 
symptoms in adults that are independent of antioxidant intake (34). Studies have shown that a 
higher consumption of fiber was protective against the development of symptoms of chronic 
bronchitis (34). Kan et al. (34) further investigated the association of dietary fiber intake with 
lung function and COPD in 11,897 participants of the Atherosclerosis Risk in Communities 
(ARIC) study. After adjusting for age, ethnicity, sex, smoking status, BMI, total energy 
intake, antioxidant (vitamin C, E, and D, and omega fatty acids), and cured meat intake, the 
10 
authors observed a positive associations between lung function and fiber intake from all 
sources (34). Participants in the higher quintile of total fiber intake had 60.2 ml higher FEV1 
(p <0.001), 55.2 ml higher FVC (p = 0.001), 0.4% higher FEV1/FVC ratio (p = 0.001) 
compared with those in the lowest quintile (34).  
Carotenoids are among the most common natural pigments that are synthesized by 
plants and microorganisms (35) with β-carotene as the most prominent. The carotenoids in 
green leafy vegetables and orange-colored fruits and vegetables are known antioxidants that 
reduce inflammation and prevent oxidative damage by counteracting the effects of free 
radicals (36). Hence, carotenoids are known to prevent human diseases, including 
cardiovascular diseases, cancer, and other chronic diseases (35). There are more than 600 
carotenoids identified in nature, but about 30 to 40 are present in a typical human diet. Of 
these 40 about 20 have been recognized in human blood and tissues. About 90% of the 
carotenoids in the diet and the human body is represented by β -carotene, α-carotene, 
lycopene, lutein, β-cryptoxanthin, α-cryptoxanthin, zeaxanthin, γ-carotene, neurosporene,     
ζ-carotene, phytofluene, and phytoene (35,37). 
Humans cannot synthesize carotenoids; instead, carotenoids must be consumed from 
diet (38). The European Prospective Investigation into Cancer and Nutrition (EPIC) study 
measured the plasma levels of six carotenoids in about 3,000 participants and found the 
following mean levels: lycopene 0.43-1.32 µmol/L, lutein 0.26-0.70 µmol/L, β-carotene 
0.21-0.68 µmol/L, β-cryptoxanthin 0.11-0.52 µmol/L, α-carotene 0.06-0.32 µmol/L, 
zeaxanthin 0.05-0.13 µmol/L (38). Although carotenoids are present in an array of fruits and 
vegetables, β-carotene and α-carotene are prominent in yellow-orange vegetables and fruits, 
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α-cryptoxanthin in orange fruits, lutein in dark green vegetables, and lycopene in tomato and 
tomato products (35). 
The primary benefits of carotenoids differ by their antioxidant potential (38). 
Carotenoids are known to be the most effective in physical and chemical suppression of 
singlet oxygen (1O2), as well as potent scavengers of other ROS (37). Hence, carotenoids are 
acknowledged to play a protective role in many ROS-mediated disorders like cardiovascular 
diseases, several types of cancer, neurological disorders, and photosensitive or eye-related 
disorders (37). Specific carotenoids can act through different mechanisms. For instance,       
β-carotene has added benefits due to its ability to be converted to vitamin A, while lutein and 
zeaxanthin absorb specific wavelengths of light which could help protect the eyes and may 
also reduce cognitive decline (38). Lycopene is known for its role in preventing cancer and 
heart diseases (35). Lastly, lutein is known to be beneficial in maternal and infant health (38).  
Like many other nutrients, bioavailability and absorption of carotenoids depend on 
several factors, including food processing and cooking. Once consumed, carotenoids are 
absorbed into the gastrointestinal mucosal cells and appear unchanged in the circulation and 
tissues (35). The carotenoids are absorbed by passive diffusion after being incorporated into 
the micelles that are formed by dietary fat and bile acids in the intestine (35). The micellular 
carotenoids are then incorporated into the chylomicrons and released through the lymphatic 
system and also into lipoproteins in the liver where carotenoids are then released into the 
blood stream (35). The distributed carotenoids are incorporated in very low-density 
lipoproteins (VLDL); thus, the resulting LDL exhibit the highest concentration of carotenes 
in plasma (37).  
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Blood concentrations of carotenoids are known to be a reliable biological marker for 
fruits and vegetable consumption (39). The major serum carotenoids are α-carotene,              
β-carotene, β-cryptoxanthin, lycopene, and zeaxanthin. The concentration of these 
carotenoids in human serum and tissues are highly variable and likely to depend on different 
factors such as food sources, the efficiency of absorption, and amount of fat in the diet (39). 
The serum carotenoid concentration after a single dose peak at 24 to 48 hours post dose (39). 
Total serum carotenoid content is not an exclusive measure of newly absorbed carotenoids. 
Therefore, the increase in carotenoids in the triglyceride-rich lipoprotein fraction – earliest 
postprandial serum appearance of carotenoids, is used to quantify carotenoid absorption (39).  
Prior epidemiological studies found a positive association between higher dietary 
intake and tissue concentration of carotenoids and lower risk of chronic diseases (35). Studies 
suggest that the antioxidant properties of carotenoids, especially α- and β-carotene and          
β-cryptoxanthin, are the main mechanism in disease prevention (35). Recent studies also 
showed that carotenoids may facilitate their effects through other mechanisms such as gap 
junction communication, cell growth regulation, modulating gene expression, immune 
response and as modulators of Phase I and II drug metabolizing enzymes (35). Carotenoids 
are also known to participate in the regulation of the cell cycle apoptosis and the modulation 
of various types of receptors or adhesion molecules and many other physiologically 
significant processes (37). 
A meta-analysis of prospective studies evaluated the associations between β-carotene 
intake or circulating β-carotene levels on the risk of all-cause mortality in general healthy 
populations (36). The study observed a favorable impact of dietary or circulating β-carotene 
on the risk of all-cause mortality among the general population in observational studies. The 
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authors explained that β-carotene in natural forms may reduce the risk of mortality in humans 
through several mechanisms. β-carotene can play an important role in its pro-vitamin A 
activity which is essential to the human body for regular tissue differentiation, organogenesis, 
immune competence, and for maintaining normal vision. β-carotene may exert physiological 
action by both antioxidant and pro-oxidant effects, which are dependent on the oxygen 
tension in the human body. With a low oxygen tension, β-carotene and other antioxidants can 
act synergistically as an effective radical-scavenging antioxidant in biological membranes. 
Moreover, β-carotene may enhance immune cell function to play a significant role in the 
prevention of chronic diseases (40).  
Past studies have reported that smokers have lower plasma carotenoid concentrations 
compared to non-smokers, in fact, the greater intensity of smoking was associated with 
decrease in serum carotenoid concentrations (39). Tobacco smoke is highly oxidative, and 
the gas phase of tobacco smoke has been shown to destroy carotenoids in in vitro studies of 
human plasma (39). Consequently, both smoke and gas-phase smoke oxidize carotenoids to 
carbonyls, epoxides, and nitro derivatives, which contribute to the reduction in circulating 
levels (39). Although smoking status increases the need for a higher intake of carotenoids to 
achieve an optimal plasma concentration of carotenoids, supplementation of carotenoids are 
generally not recommended as carotene supplements have been suggested as causing adverse 
effects in smokers (39).  
An association of vitamin A status and the rate of COPD was observed in a cross-
sectional study. The purpose of this study was to examine if vitamin A deficiency is 
associated with COPD (41). The study assessed healthy nonsmokers and smokers and COPD 
patients. Sixty-five adult male subjects aged between 43 and 74 were recruited in the study. 
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Data for smoking habits, pulmonary function tests, and energy-protein status were collected 
(41). Serum concentrations of retinyl esters, retinol, retinol-binding protein, and transthyretin 
and relative dose responses were measured (41). A significantly lower serum concentration 
of retinol was observed in the COPD groups (41). 
It is evident that oxidative stress contributes to airflow limitation, making the 
association between antioxidants and pulmonary function more apparent in individuals with 
COPD compared to general healthy population. Because of the higher needs of antioxidants 
among individuals with limited pulmonary function, the antioxidant status may be important 
in the progression of pulmonary diseases (42). Ochs-Balcom et al. (42) studied the 
association between antioxidant nutrients and oxidative stress biomarkers with pulmonary 
function in persons with chronic airflow limitation. The authors hypothesized that antioxidant 
vitamins would be positively related to pulmonary function, while oxidative stress markers 
may be negatively associated with pulmonary function in patients with a limited airflow.  
The study participants were tested for pulmonary function, and fat-soluble vitamins in 
serum were measured using a high-pressure liquid chromatography system. Nutrient intake 
was assessed over the 12-month period using the self-administered 100 item food frequency 
questionnaire. Then, individual mean daily nutrient intakes were calculated (42). Of the 218 
study participants, 66% were current and former cigarette smokers with a mean of 24.4 pack-
years of smoking. Adjusting for covariates, multiple linear regression analysis showed that 
serum β-carotene, lutein, zeaxanthin, and retinol, and dietary β-carotene, β-cryptoxanthin, 
lutein, zeaxanthin, lycopene, and vitamin C were positively associated with FVC percentage 
(p <0.05) (42). Partial correlation coefficients (r) among serum vitamins ranged from 0.16 to 
0.44, where the strongest correlation was found among β-cryptoxanthin and lutein/zeaxanthin 
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(r = 0.43, p  <0.001) and vitamin E with β-carotene (r = 0.42, p <0.001) (42). Of the dietary 
vitamins, β-carotene and lutein (r = 0.70, p <0.001) had the strongest correlation (42). The 
authors of this study suggested that β-cryptoxanthin and lutein/zeaxanthin are more strongly 
associated with pulmonary function than β-carotene which strengthens the evidence that the 
antioxidant/oxidant balance is associated with pulmonary function and that carotenoids may 
play an important role (42). 
A study performed by Semba et al. (8) examined the relationship between the major 
serum carotenoids, α-carotene, β-carotene, β-cryptoxanthin, lutein/zeaxanthin, and lycopene, 
with pulmonary function. The study hypothesized that serum carotenoids were associated 
with pulmonary function in older women. To address this hypothesis, the researchers 
measured serum carotenoids and assessed pulmonary function in 1,002 women, aged 65 
years and older, who participated in the Women’s Health and Aging Study I (WHAS I) (8). 
Results showed a positive association between higher serum α-carotene and β-carotene 
concentrations and FEV1 and FVC (all p < 0.05) in separate multivariate linear regression 
models adjusting for age, race, education, cognition, anemia, inflammation, and chronic 
diseases (8). Total serum carotenoids were associated with FEV1 (p = 0.08) and FVC           
(p = 0.06), respectively, in similar models; however, the study did not find an association 
between β-cryptoxanthin, lutein/zeaxanthin, and lycopene, and FEV1 or FVC (8).   
Grievink et al. (43) designed a study to observe the association between serum 
carotenoids, α-tocopherol, and lung function among non-institutionalized Dutch subjects ages 
65 to 85 years. Multiple linear regression analysis was performed adjusting for age, gender, 
height, and cigarette-years of smoking. Based on FEV1 and FVC values, 47% of the study 
participants had airway obstruction (43). The authors reported that FEV1 was highly 
16 
correlated with age, height, physical activity score, and serum cholesterol, but not with BMI 
(43). Lower FEV1 and FVC were observed among former and current smokers compared to 
non-smokers (43). The study found significantly positive trends between α-carotene,            
β-carotene, lycopene, and FEV1 (p < 0.05) and between α-carotene, β-carotene, and FVC        
(p < 0.05) (43). Although lycopene was associated with FEV1, it was not significantly 
associated with FVC (43). A possible reason, as the authors noted, could be that most 
carotenoids were measured in serum and in lung tissue, in which the proportion of lycopene 
in the lung tissue was slightly lower, and α-carotene was higher compared with the 
proportion of the other carotenoids in serum levels (43). Therefore, the concentration of 
lycopene and α-carotene in the blood may not represent the actual value in lung tissue (43).  
A study examined the relationship between lung cancer risk and intakes of the five 
carotenoids in two large cohorts. Baseline questionnaires asked participants to report their 
average frequency of intake over the previous year of a specified serving size of specific 
carotenoid containing foods (44). Carotenoid intakes were derived from the reported 
consumption of fruit and vegetables on the questionnaire (44). Smoking status and history 
and specified medical conditions were assessed at baseline and in all subsequent 
questionnaires in both cohorts. After the 12-year follow-up period, the study found that         
α-carotene and lycopene intakes were significantly associated with a lower risk of lung 
cancer (p <0.05); the association with β-carotene, lutein, and β-cryptoxanthin intakes were 
inverse but not significant (44). Additionally, lung cancer risk was significantly lower in 
subjects who consumed a diet high in a variety of carotenoids (RR: 0.68; 95% CI: 0.49, 0.94 
for highest compared with lowest total carotenoid score category) (44).  
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Lycopene is the most abundant carotenoid in tomatoes and tomato products such as 
ketchup and pasta sauce. Epidemiological studies show that high intake of tomatoes and 
tomato products containing high levels of lycopene, exhibit a lower risk of lung cancer (31). 
Lycopene is also known to have anti-tumoral activity in lung tumorigenesis. The high 
number of conjugated double bonds in lycopene endows it the singlet oxygen quenching 
ability as compared to vitamin E or β-carotene (20). The chemical structure of lycopene is an 
electron-rich system making it unstable and highly reactive towards oxygen and free radicals 
(31). This reactivity of lycopene is the base of its antioxidant activity in biological systems. 
Additionally, lycopene may exert modulatory action on cancer by up-regulating antioxidant 
response element leading to the synthesis of cytoprotective enzymes, enhancing intercellular 
gap junction communication, modulating the hormonal, inflammatory and immune system, 
and metabolic pathways (31).  
An animal study investigated whether lycopene reverses long-term lung damage 
caused by cigarette smoke exposure. The authors hypothesized that administration of 
lycopene would repair lung damage in emphysema induced by cigarette smoke exposure. In 
the study, mice were divided into five groups: control group, oil group, group exposed to 
cigarette smoke, group administered with 25 mg of lycopene and exposed to cigarette smoke, 
and groups administered with 50mg of lycopene and exposed to cigarette smoke. Within the 
two groups that were given a dose of lycopene, half was exposed to 60 days of cigarette 
smoke, and the other was not. The study found an increased number of circulating 
inflammatory cells and increased levels of inflammatory cytokines (p <0.05) in the group that 
was exposed to cigarette smoke (14). In contrast, there was a reduction in the number of total 
leukocytes, reduced cytokines, and improved pulmonary emphysema among the lycopene 
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administered mice as determined by the number of macrophages, neutrophils, lymphocytes, 
and inflammatory cytokines (14). In summary, lycopene promoted a reduction in the number 
of total leukocytes and improved pulmonary emphysema. The authors also observed 
minimized redox processes due to a decrease in lipid peroxidation and DNA damage and an 
increase in the activities of superoxide dismutase (SOD), catalase (CAT), and GSH content 
(14). 
A randomized clinical trial in 2012 observed the effect of lycopene on oxidant stress 
and pulmonary function tests (PFT) in patients with COPD (45). Fifteen clinically stable 
COPD patients and 15 healthy non-smoker control subjects were divided into two groups. 
One group received oral placebo, and the other group received 20 mg lycopene supplement 
daily for four months in addition to their standardized therapy. Their baseline spirometry, 
plasma malondialdehyde (MDA), SOD, CAT, interleukin (IL)-6, IL-1β, and tumor necrosis 
factor-α levels were measured in serum (45). At the beginning of the trial, the COPD group 
had higher baseline mean MDA, IL-6, IL-1β, and TNF-α levels and lower SOD and CAT 
levels compared to controls (45). After four months of lycopene supplementation, however, 
significant increases in mean SOD, and CAT levels (p <0.001), and significant decreases in 
mean MDA, IL-6, IL-b, and TNF-a levels (p = 0.001, p <0.001, p = 0.002, p <0.001, 
respectively) were observed in the  lycopene-supplemented patients, suggesting that lycopene 
supplementation may have favorable effects on oxidant-antioxidant balance in patients with 
COPD (45). The study found no significant increase in FEV1/FVC ratio (45). 
The Military and Veteran’s Health Study examined the intake and serum levels of 
nutrients previously associated with lung health in a population of veterans with COPD (46). 
A secondary analysis of data was obtained from a cross-sectional study of agricultural 
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exposures and COPD in veterans. A subject was considered to be a smoker if they had 
smoked more than 100 cigarettes in their lifetime. A food frequency questionnaire (FFQ) was 
used to determine absolute nutrient intake values from foods and supplements. Serum levels 
of the five carotenoids were measured. For statistical analysis, descriptive statistics were 
calculated for all variables, and a Spearman correlation coefficient was used to look at the 
association between serum carotenoid levels and the lung function measures (FEV1/FVC 
ratio). The study documented lower serum levels of β-cryptoxanthin and carotenes among 
smokers (46). Additionally, there was a correlation between dietary β-cryptoxanthin and the 
high serum level of this compound with the decreased rates of COPD (46).  
 Rautalahti et al. (47) studied the effect of α-tocopherol and β-carotene 
supplementation on COPD symptoms. This study aimed to investigate whether 
supplementation with α-tocopherol and β-carotene could affect the recurrence and incidence 
of COPD-related symptoms and whether dietary intake and serum levels of those substances 
were related to the prevalence of COPD symptoms in a cohort of smokers (47). Subjects 
were current smokers of at least five cigarettes daily and had smoked for a median of 36 
years. Results indicated that supplementation with α-tocopherol or β-carotene for five to 
eight years did not prevent the development of COPD, but a diet rich in carotenoids offered 
some protection even among elderly, long-term smokers (47). There are possible 
explanations for why the supplementation of carotenoids did not offer protection against free 
radicals: the antioxidant supplementations may have been given too late or for too short a 
period of time, or the high levels of antioxidants may have disturbed a balance between 
oxidants and various antioxidants (47).   
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Studies in the past have documented a potentially harmful effect of carotenoids on 
lung outcomes with an increased risk for lung cancer and mortality among smokers (15). 
Studies found that supplementation of high doses of β-carotene increased the risk of lung 
cancer in smokers (48). The National Institute of Health explained several reasons for this. 
First, the beneficial health effects of a diet high in vegetables and fruits or other antioxidant-
rich foods may actually be caused by other substances present in the same foods, other 
dietary factors, or other lifestyle choices rather than antioxidants. The effects of the large 
supplemental doses of antioxidants used in the studies may be different from those of the 
smaller amounts of antioxidants normally consumed in foods. Lastly, the effects of the 
different chemical composition of antioxidants in foods and those in supplements may have 
influenced the result (48).  
The results of the studies that observed the role of β-carotene in airway obstruction 
are inconsistent. Several prospective studies found a weak inverse association between 
dietary carotenoids and adult-onset asthma, and some studies found no association between 
baseline β-carotene intake and COPD mortality (6). These contradictory results may be due 
to measurement error, the choice of the dietary instrument, and the differences in outcome 
assessment. 
 These conflicting results, coupled with the current lack of effective treatments for 
COPD, indicate a need for further research into possible preventative measures. The present 
study aims to analyze the association between dietary intake of carotenoids and pulmonary 
function outcomes among participants of the Atherosclerosis Risk in Communities (ARIC) 
study. Based on the previous results from similar studies, it is hypothesized that there is an 
inverse relationship between the intake of carotenoids and carotenoid-rich foods and the rates 
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of COPD, with higher intakes of carotenoids and carotenoid-rich foods being associated with 
lower rates of COPD. 
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Chapter Two 
Abstract 
Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory disease 
causing more than three million deaths annually around the world. Previous studies have 
shown an increased incidence of COPD among smokers. Studies also have shown 
antioxidant nutrients such as carotenoids, have been associated with lower rates of COPD. 
Objective: To investigate if the consumption of carotenoids and carotenoid-rich foods is 
associated with higher pulmonary function. 
Methods: Data were taken from the Atherosclerosis Risk in Communities (ARIC) study, 
which included approximately 15,000 individuals aged 45-64 years at baseline. Dietary 
intake of carotenoids and carotenoid-rich foods were assessed. Total carotenoid intake was 
calculated by summing five specific carotenoids: α-carotene, β-carotene, β-cryptoxanthin, 
lycopene, and lutein/zeaxanthin. Pulmonary function was evaluated as the ratio of forced 
expiratory volume in one second [FEV1] and forced vital capacity [FVC]. Linear regression 
analysis was used to assess the association between the intakes of carotenoids and 
carotenoid-rich foods. Significance level was p <.05. 
Results: A positive association between the total carotenoid intake with pulmonary function 
was only marginally significant; however, α-carotene, β-carotene, and β-cryptoxanthin were 
positively (p =.001, p =.003, p =.007, respectively) associated with FEV1/FVC ratio in study 
participants. Food sources of these pro-vitamin A carotenes were also (p =.008) positively 
associated with FEV1/FVC ratio. 
Conclusions: This study suggests a possible role for certain provitamin A carotenes, and their 
associated foods in pulmonary health. 
Keywords: diet; carotenoids; pulmonary; pulmonary function; lung; COPD 
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Introduction  
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in 
the world and is projected to be the third leading cause of death by 2020 (1). According to 
the Global Initiative for Chronic Obstructive Lung Disease (1), more than three million 
people died of COPD in 2012, which is six percent of all deaths globally. Based on large 
scale epidemiological studies, the number of COPD cases was estimated to be 384 million in 
2010, with a global prevalence of 11.7% (95 CI 8.4%-15.0%) (1). 
COPD is an inflammatory disease leading to obstructive lung airways and airflow 
limitations (2) that interferes with normal breathing (3). A COPD diagnosis is considered in 
any patient who has symptoms of a chronic cough, sputum production, dyspnea, and a 
history of exposure to risk factors for the disease (4). The diagnosis is confirmed by a 
spirometry test, which measures how fast air can move out of the lungs and how deeply a 
person can breathe (5). More specifically, the ratio of the forced expiratory volume in 1 
second (FEV1) to the total vital capacity (FVC) is used to define the severity of the disease 
(6). COPD is classified by a FEV1/FVC ratio of less than 70% or by an FEV1 less than 80% 
of that predicted by age, sex, ethnicity, and standing height (7). 
The development of COPD is mainly due to biological factors such as inflammation 
and oxidative stress caused by free radicals, and inadequate intake of antioxidant-rich foods 
(8). Augmented pollution from rapid industrialization and increases in the smoking rates 
worldwide also increase risk for developing COPD (9). According to Scanlon et al. (10), risk 
factors that contribute to the development of COPD include tobacco smoking, poor initial 
lung function, advanced age, male sex, childhood respiratory illness, occupational respiratory 
exposures, air pollution, low educational attainment or socioeconomic status, and other 
familial factors.  
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Carotenoids are among the most common natural pigments that are synthesized by 
plants and microorganisms (35) with β-carotene as the most prominent. The carotenoids in 
green leafy vegetables and orange-colored fruits and vegetables are known antioxidants that 
reduce inflammation and prevent oxidative damage by counteracting the effects of free 
radicals (36). Recent studies also showed that carotenoids may facilitate their effects through 
other mechanisms such as gap junction communication, cell growth regulation, modulating 
gene expression, immune response and as modulators of Phase I and II drug metabolizing 
enzymes (35). 
A study performed by Semba et al. (8) examined the relationship between the major 
serum carotenoids, α-carotene, β-carotene, β-cryptoxanthin, lutein/zeaxanthin, and lycopene, 
with pulmonary function. Results showed a positive association between higher serum         
α-carotene and β-carotene concentrations and FEV1 and FVC (p < 0.05) in separate 
multivariate linear regression models (8).   
In contrast, some studies observed no association between carotenoid intake and 
COPD risk. A community-based Korean Genome Epidemiology Study (KoGES) study found 
a decreased risk of COPD with increase in the dietary vitamin A and vitamin E intake in men 
(49). Furthermore, the lung function was significantly improved with increase in vitamin C 
and E intake (49). However, the study found no significant association in baseline vitamin A 
or β-carotene intake and the COPD risk, suggesting a nonbeneficial effect of β-carotene in 
human lung (49). 
These conflicting results, coupled with the current lack of effective treatments for 
COPD, indicate a need for further research into possible preventative measures. The present 
study aims to further analyze the association between dietary intake of carotenoids and 
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carotenoid-rich foods and pulmonary function outcomes among participants of the 
Atherosclerosis Risk in Communities (ARIC) study. Based on the previous results from 
similar studies, it is hypothesized that there is a positive relationship between the intake of 
carotenoids and carotenoid-rich foods and the FEV1/FVC ratio. 
Materials and Methods 
Study Population 
 The Atherosclerosis Risk in Communities Study (ARIC), sponsored by the National 
Heart, Lung, and Blood Institute (NHLBI), is a large prospective epidemiologic study 
designed to examine the risk factors for and clinical outcomes of atherosclerosis by race, 
gender, and location. The study randomly selected and recruited approximately 15,000 
individuals aged 45-64 years from four communities in the U.S.: Forsyth County, North 
Carolina; Washington County, Maryland; the suburbs of Minneapolis, MN; and, the City of 
Jackson, Mississippi (50). A total of 15,792 participants received extensive examinations, 
including medical, social, and demographic data. Follow-up occurred semi-annually by 
telephone, to assess health status of the cohort, and reexamination occurred every three years 
with the baseline visit taking place in 1987-89 (51,50). 
Dietary Intake and Carotenoid Level 
 The participants’ average dietary intake data were collected by an interviewer using a 
66-item, semiquantitative food frequency questionnaire (FFQ), a modified version of the    
61-item questionnaire developed by Walter Willett (50). The major modification was the 
inclusion of an interviewer trained to use a standardized procedure for administrating the 
dietary questionnaire (50). Participants were asked how often on average they had consumed 
a specified portion size of each food during the preceding year with nine response categories 
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available. Daily nutrient intake was calculated by multiplying the nutrient content of the 
specified portion of each food item by the frequency of its daily consumption and summing 
over all items. For this study, daily intakes of the five carotenoids, α- and β-carotene,           
β-cryptoxanthin, lycopene, and lutein/zeaxanthin, were calculated from the ARIC FFQ, then, 
the total carotenoids were calculated. Intake of carotenoid-rich foods was calculated by 
adding the number of servings consumed daily of fruits and vegetables that are rich in each 
carotenoid.  
Pulmonary Function 
 Pulmonary Function Assessment is one of the series of protocols and manuals of 
operation for the ARIC study. The pulmonary function was measured at visit 1 and 2 using 
Collins Survey II volume displacement spirometer which is connected to an IBM PC/XT 
computer (52). A spirometry summary and interpretation from the IBM Proprinter was 
created for each ARIC study participant (52). A technician coached the participant both to 
maximal inspiration and to maximal expiration. Participants made five attempts to obtain 
three measurements that were considered acceptable. The technician also judged the 
acceptability and quality of the subject’s effort. As a subject blow into the spirometer, the 
spirogram paper displays a volume-time tracing while the computer displays flow-volume 
curves for operator assessment. At the same time, the computer makes multiple quality 
measurements of each maneuver. A message then is displayed when at least two out of three 
tests are reproducible (52). The computer then prints a summary of the subject’s results from 
the data file at the end of each session and then stores the raw data from each test in the file 
generated for that subject. For the present analysis, pulmonary function was evaluated as a 
27 
ratio of the forced expiratory volume in one second [FEV1] and forced vital capacity [FVC] 
and diagnosis of COPD was evaluated as a FEV1/FVC ratio of less than 70%. 
Demographic and Other Confounding Variables 
  Other information, including age, height, weight, gender, ethnicity, energy intake, 
smoking status, education level, physical activity level, and medical and personal information 
were collected during the clinical examination and home interview at baseline (50). 
Experienced and trained interviewers were employed to conduct data collection activities. 
Anthropometric measurements were taken by technicians. Results for standing body height 
was recorded to the centimeter, rounding down. The participant’s body weight was recoded 
to the pound, rounding down (50). Self-reported smoking status was classified as current 
smoker, non-smoker, or past-smoker (50). Cigarette-years of smoking were assessed. Body 
mass index (BMI) was calculated as weight (kg)/height(m)2. Education was recorded as a    
3-step scale, basic education or less than a high school degree, intermediate education with a 
high school degree but less than a 4-year degree, or advanced education with a 4-year degree 
or beyond. Physical activity level was quantified as tertiles of the sum of work, sports, and 
leisure time activities.  
Statistics 
 Study participants who met the following criteria were excluded: ethnicity other than 
African American or white; missing data on spirometry or intake of carotenoids; FVC1/FEV 
ratio of less than 40% or more than 95%; carotenoids intake of more than 40mg per day; and 
missing or incomplete information for covariates, including smoking status and total energy 
intake. The final study sample consisted of 13,825 adults.  
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 Linear regression models of total dietary intake of carotenoids versus pulmonary 
function were created, controlling for age, sex, ethnicity, education level (3 levels), standing 
height (centimeters), BMI, smoking status, cigarette-years of smoking, total energy intake, 
total physical activity level, vitamin C intake, and total cholesterol level. 
All statistical analysis was performed using IBM SPSS Statistics, version 24 (IBM 
Corp., Armonk, NY).  
Results 
A total of 13,825 participants were assessed for inclusion in the present study. Study 
participants were female (55%, n = 7,832), black (25%, n = 3,593) with advanced level 
education (35.4%). Ages at baseline ranged from 44 to 66 years. Mean BMI was 27.7 ± 5.3. 
Current smokers had smoked an average of 639.7 ± 444.2 cigarette-years. Table 1 shows the 
characteristics of the study cohort by smoking status.  
Overall FEV1/FVC ratio in this cohort was low; never smokers, past smokers, and 
current smokers had an average percentage of 76.9 ± 6.0, 74.1 ± 7.4, and 71.4 ± 8.7 
respectively (Table 1). Average total carotenoid intake was 8.9 ± 6.5 mg per day.  
Linear regression comparing total carotenoid intake alone and FEV1/FVC ratio at 
visit 1 showed a significant univariate association (p = 0.016). An analysis controlling for 
demographic variables including black ethnicity, female gender, and age attenuated this 
association with the FEV1/FVC ratio (p = 0.057). Finally, an analysis controlling for the 
demographic variables and other important covariates including education level, smoking 
status, cigarette-years of smoking, BMI, physical activity level, total energy intake, and 
standing height showed a marginal significant association (p = 0.038) (Table 2). A similar 
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marginal association between FEV1/FVC ratio and carotenoid intake was found in all of the 
smoking subgroups.  
Each carotenoid was analyzed separately through a multivariate linear regression. 
FEV1/FVC ratio showed a promising positive association with α-carotene, β-carotene, and   
β-cryptoxanthin. Lycopene and lutein/zeaxanthin showed no significant association with 
FEV1/FVC ratio (Table 3). These results show possibly differing roles of various dietary 
carotenes in lung health. 
After controlling for vitamin C, both α-carotene, β-carotene, and β-cryptoxanthin had 
a significant association with FEV1/FVC ratio (p < 0.001 and p < 0.008, respectively), which 
shows that both carotenes are highly associated with a better pulmonary function independent 
of the other important antioxidant vitamin source in fruits and vegetables (Table 3).  
Additionally, total servings of fruits and vegetables that are high in α-carotene,         
β- carotene, and β-cryptoxanthin, such as oranges, orange juice, peaches, carrots, winter 
squashes, and sweet potatoes, were analyzed (Table 4) to see their association with 
FEV1/FVC ratio. Orange- and yellow-colored fruits and vegetables intakes were observed to 
be significantly associated with FEV1/FVC ratio (p = 0.008) (Table 5). In contrast, intake of 
fruits and vegetables that are high in lycopene and lutein/zeaxanthin, such as cabbage, 
tomatoes, greens, corns, peas and lima beans, and pasta, had no association on pulmonary 
function. The ARIC study participants ate an average of 2.0 ± 1.5 servings of fruits and      
1.4 ± 0.9 servings of vegetables daily. 
Discussion 
 The present study shows marginally significant association between the total 
carotenoid intake and pulmonary function, which rejects the null hypothesis. We found 
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differences among the carotenoids, with a higher intake of α-carotene, β-carotene, and         
β-cryptoxanthin being positively associated with pulmonary function in adults, as expressed 
by FEV1/FVC. Foods rich in these carotenoids were also found to be associated with a higher 
FEV1/FVC ratio.  
These findings are consistent with past studies that have found a significant 
association between both α- and β-carotenes and lung function (8,43). Although past studies 
did not show a significant association between β-cryptoxanthin and FEV1 or FVC, they 
found a marginal association between lycopene and lung function (43) similar to the present 
study. The present study assessed dietary intake of carotenoid-rich foods instead of serum 
carotenoid levels which could have led to different results than the past studies.  
The present study considered all confounding factors, such as sex, age, education 
level, BMI, total calorie intake, height, smoking status, pack-years of cigarette smoking, 
physical activity level, and total serum cholesterol level, in the association between 
carotenoid-rich food intake and FEV1 or FVC ratio. A significant association was observed 
after taking these confounders into account. However, there may have been measurement 
error in the confounding variables in which residual bias might have occurred. 
The present study observed significant associations of certain carotenoids in lung 
function. A past study that looked at dietary total carotene in relation to lung function stated 
that different carotenoids might have individual effect on lung physiology (53). In an animal 
study, three months of β-cryptoxanthin supplementation substantially reduced smoke-
elevated inflammation in lung tissues (54). The authors explained that the beneficial effects 
of β-cryptoxanthin on lung function observed in this study were not due to its pro-vitamin 
activity but due to its anti-inflammatory and anti-oxidative DNA effects in the lungs (54).    
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In contrast to the above studies, Schünemann et al. (55) found the strongest 
correlation between intake of lutein/zeaxanthin and pulmonary function, significantly with 
FVC. This population-based study examined the five carotenoids and found no association 
between β-cryptoxanthin intake. The authors explained that this lack of an association may 
be the result of the difficulties associated with accurately measuring β-cryptoxanthin in the 
diet (55). 
According to USDA Food Composition Databases (56), foods that are high in          
α-carotene include carrots and winter squashes. β-carotene is rich in sweet potatoes, carrots, 
and greens such as spinach. β-cryptoxanthin is rich in winter squashes and oranges. Carrots, 
sweet potatoes and winter squashes are abundant in all α-carotene, β-carotene, and               
β-cryptoxanthin. Statistical correlations in the ARIC dataset indicated that all fruits, 
vegetables, legumes, and nuts were significantly associated with α-carotene, β-carotene, and 
β-cryptoxanthin. More specifically, carrots had the highest association with both α-carotene 
and β-carotene, and oranges had the highest association with β-cryptoxanthin. Processed 
foods such as commercially baked goods, meats, eggs, dairy, and wine had limited or no 
associations with these. The consumption of fruits and vegetables rich in α-carotene,            
β-carotene, and those rich in β-cryptoxanthin and lycopene and lutein/zeaxanthin was 
analyzed across smoking status (Table 5). Study participants ate about 1.5 servings of 
carotene-rich fruits and vegetables and 1 serving of lutein/zeaxanthin-rich fruits and 
vegetables daily. Among the three groups, never smokers ate more servings of carotenoid-
rich fruits and vegetables.  
Total servings of pasta among the ARIC study participants were calculated since most 
lycopene is consumed from tomato products such as pasta sauce. Certainly, pasta 
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consumption was correlated with lycopene intake; however, it was not significantly 
associated with pulmonary function in this cohort. 
There are possible explanations for these results. Lycopene is mostly consumed from 
tomatoes and tomato products including pizza and pasta which are not considered vegetables. 
For which, higher consumption of pizza and tomato-based pasta dishes may not have a 
positive effect in pulmonary function.  
Lutein/zeaxanthin comes mostly from green vegetables such as spinach, kale, and 
lettuce. Intake of lutein/zeaxanthin-rich fruits and vegetables were not significantly 
associated with pulmonary function.  
Other antioxidant nutrients are thought to be protective of lung function in adults. 
Vitamin C, vitamin E, flavonoids, and selenium are examples of these antioxidants. These 
are present in a variety of fruits and vegetables that are also high in α-carotene, β-carotene, 
and β-cryptoxanthin. Thus, we cannot conclude that carotenoids are the only nutrients 
playing a role in lung function. In the present study, adjusting for vitamin C intake, however, 
still found significant associations between both α- and β-carotenes and FEV1/FVC ratio.  
A past study suggested that improving the diet, by increasing fresh fruits and 
vegetable consumption, rather than of vitamin supplements, will be beneficial in protecting 
airway diseases (57). As five carotenoids can be consumed from food sources, including 
carrots, sweet potatoes, tomatoes, etc., consumption of fruits and vegetables as a whole may 
be the best way to increase carotenoids intake along with the other antioxidant nutrients. A 
study examined the association of self-reported intake of fruit and vegetables and COPD in a 
population-based twin study and found a significant frequency-dependent association 
between fruit and vegetable intake and risk of COPD (30). The study suggested that a low 
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intake of fruits and vegetables is associated with an increased risk of COPD (30). This 
information, coupled with the present study results, shows that higher intake of fruits and 
vegetables, especially those rich in carotenoids, are beneficial for lung health.  
One of the strengths of the present study was the large population-based sample of 
ARIC study participants. The ARIC study included adults who are at higher risk of decreased 
pulmonary function. The study also included measurement of all five major dietary 
carotenoids and spirometry measurements of lung function. Lastly, the ARIC study had 
relevant possible cofactors such as smoking status, physical activity level, BMI, and total 
energy intake. 
This study has several limitations. The present study was a cross-sectional study 
which assumes that the assessed diet had been in place for some time so as to predispose for 
the lung condition. It is possible that the covariate intake of other antioxidant nutrients such 
as vitamin C, vitamin E, and selenium may confound the apparent carotenoid association. 
The ARIC study assessed nutrient intakes using the FFQ method, which may have caused 
limitations such as measurement error in the portion sizes and inaccuracies that resulted from 
limited food choices. Another limitation is that the ARIC study only recruited adults older 
than 45, in which case the results cannot necessarily be extrapolated to a younger population. 
Lastly, we did not control for the geographical locations of the four ARIC study centers 
which may have affected the lung function of the study participants depending on the 
environment. 
In conclusion, although this present study showed only a marginal association 
between lung function and total carotenoid intake, a promising association with pro-vitamin 
A carotenoids, including α-carotene, β-carotene, and β-cryptoxanthin, was seen with 
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FEV1/FVC ratio. There was no significant association between lycopene, and 
lutein/zeaxanthin with FEV1/FVC ratio. These results support other findings that suggest 
individuals, especially those with reduced pulmonary function, should increase their 
consumption of fruits and vegetables, especially those rich in α-carotene, β-carotene, and β-
cryptoxanthin. Further controlled dietary intervention studies are needed to determine 
whether an increased intake of fruits and vegetables can reverse the decrease in FEV1/FVC 
ratio in the adult population. 
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Tables 
 
Table 1. Characteristics of Participants from the ARIC Cohort. 
Characteristic Never smoker Past smoker Current 
smoker 
p-valuea 
n 5430 4471 3924  
Age at visit 1 (y) 54.1 ± 5.8 54.8 ± 5.8 53.8 ± 5.6 <0.001*** 
Female gender (%) 74% 38% 48% <0.001*** 
Black ethnicity (%) 29% 18% 28% <0.001*** 
Education, post high school (%) 37.0% 39.7% 29.3% <0.001*** 
Standing height (cm) 166 ± 9 171 ± 9 170 ± 9 <0.001*** 
BMI (kg/m2) 28.3 ± 5.7 28.1 ± 5.0 26.5 ± 4.9 <0.001*** 
Cigarette-years of smoking 0 444 ± 434 637 ± 444  <0.001*** 
Total energy (kcal/day) 1559 ± 567 1625 ± 606 1662 ± 634 <0.001*** 
Total cholesterol (mmol/L) 5.5 ± 1.1 5.6 ± 1.1 5.6 ± 1.1 0.126 
Total carotenoids (mg/day) 9.2 ± 6.4 8.9 ± 6.5 8.6 ± 6.5 <0.001*** 
Total physical activity score 6.9 ± 1.4 7.1 ± 1.4 6.8 ± 1.5 <0.001*** 
FEV1/FVC for visit 1 (%) 77 ± 6 74 ± 7 71 ± 9 <0.001*** 
Values are expressed as percentages or as mean ± SD, p values are based on ANOVA 
statistics 
 
a. p values are for the comparison between never smokers, past smokers, and current 
smokers.   
*p < 0.05, **p < 0.01, ***p < 0.001 
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Table 2. Association Between Carotenoid Intake and FEV1/FVC Ratio. 
 Betaa Confidence Interval p-value 
Univariate 0.024 0.004, 0.043 0.016* 
Demographicb 0.018 -0.001, 0.037 0.057 
Multivariatec 0.020 0.002, 0.039 0.033* 
a. Beta value is the change in FEV1/FVC ratio for each mg increase in total carotenoid 
intake. 
Units of beta FEV1/FVC% per mg carotenoid 
b. Demographic linear regression controls for sex, age, and race 
c. Multivariate linear regression controls for sex, age, education level, BMI, total calorie 
intake, standing height, smoking status, cigarette-years of smoking, physical activity 
level, and total serum cholesterol level. 
*p < 0.05, **p < 0.01, ***p < 0.001 
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Table 3. Association Between Each Carotenoid Intake and FEV1/FVC Ratio. 
 Beta Confidence Interval p-value 
α-carotene 0.338 0.159, 0.517 <0.001*** 
β-carotene 0.080 0.027, 0.133 0.003** 
β-cryptoxanthin 1.868 0.506, 3.229 0.007** 
Lycopene 0.018 -0.015, 0.050 0.283 
Lutein and Zeaxanthin 0.004 -0.045, 0.054 0.861 
    
With Vitamin C as a Covariate 
 Beta Confidence Interval p-value 
Total carotenoids 0.017 -0.002, 0.037 0.078 
α-carotene 0.324 0.142, 0.505 <0.001*** 
β-carotene 0.074 0.019, 0.129 0.008** 
β-cryptoxanthin 1.864 0.190, 3.539 0.029* 
Lycopene 0.014 -0.018, 0.047 0.394 
Lutein/zeaxanthin -0.005 -0.056, 0.046 0.844 
Units of beta FEV1/FVC% per mg carotenoid 
Multivariate linear regression same as Table 2. 
*p < 0.05, **p < 0.01, ***p < 0.001 
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Table 4. Servings of Carotene-Rich vs. Lycopene and Lutein/Zeaxanthin Fruits and 
Vegetables Across Smoking Status. 
Characteristic Never 
smoker 
Past 
smoker 
Current 
smoker 
p-value 
F & V rich in carotenes 1.7 ± 1.2 1.6 ± 1.1 1.3 ± 1.1 <0.001*** 
F & V rich in lutein/zeaxanthin 1.1 ± 0.7 1.0 ± 0.7 1.0 ± 0.7 0.343 
Values are expressed as percentages or as mean ± SD, P value is based on 
ANOVA statistics 
 
*p < 0.05, **p < 0.01, ***p < 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
46 
Table 5. Association Between Carotenoid-Rich Food Sources and FEV1/FVC Ratio. 
 Beta Confidence Interval p-value 
F & V rich in carotenes 0.146 0.038, 0.253 0.008** 
F & V rich in lycopene & lutein/zeaxanthin 0.061 -0.124, 0.245 0.518 
Units of beta FEV1/FVC% per serving of carotenoid-containing foods. 
Multivariate linear regression same as Table 2. 
*p < 0.05, **p < 0.01, ***p < 0.001 
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